• Bienvenidos a nuestra página web www.biologiamolecularmexico.com

  • Conoce nuestra Tienda en Línea y con ello apoya el proyecto.

  • Informate de todas las noticias y eventos de biología molecular

Porfavor considera apoyar nuestro esfuerzo.

Cantidad a donar:
Lunes, 26 Octubre 2020 22:26

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Valora este artículo
(0 votos)
Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the
Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.
Visto 102 veces

Deja un comentario

Asegúrese de introducir toda la información requerida, indicada por un asterisco (*). No se permite código HTML.